Retifanlimab Wins Upfront Indication for Anal Cancer ...Middle East

Medscape - News
Retifanlimab Wins Upfront Indication for Anal Cancer
The anti-PD-1 antibody was approved as first-line treatment for locally recurrent or metastatic squamous cell anal carcinoma. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Retifanlimab Wins Upfront Indication for Anal Cancer )

Also on site :

Most viewed in News